Brain-Boosting tablet workout tested for memory loss

NCT ID NCT07101380

Ongoing Symptom relief Sponsor: Ajou University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a tablet-based exercise program called SuperBrain BOOM can improve thinking, memory, and physical function in older adults with mild cognitive impairment (MCI). Forty-five participants aged 50-85 will use the program at home or in a clinic for 12 weeks, while a control group receives usual care. The goal is to see if the program is safe, engaging, and effective at slowing cognitive decline.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SuperBrain BOOM (tablet-based physical activity program)
What this could lead to: If it works, this could offer a simple, home-based exercise program to help slow cognitive decline and improve quality of life for people with mild cognitive impairment.
What could go wrong: This is a small, early-stage exploratory study with only 45 participants. The program may not show significant benefits, and results may not apply to everyone with MCI.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT (MCI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MILD COGNITIVE IMPAIRMENT (MCI)

Contacts and locations

Locations

Ajou University Hospital

Suwon, Gyeonggi-do, 16499, South Korea
Bundang CHA General Hospital

Seongnam-si, Gyeonggi-do, South Korea
Chonnam National University Hospital

Gwangju, South Korea
Pusan National University Hospital

Busan, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.